NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MicroMGx

MicroMGx

Private
Evanston, IllinoisHealthcare & Life Scienceshttps://micromgx.com/

Last Round

Accelerator

Jan 9, 2025

Total Funding Raised

$874,508

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MicroMGx is a life sciences company that provides a metabologenomics platform to accelerate the discovery of novel natural products for pharmaceutical, agricultural, and animal health applications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

natural product discoverydrug discoverybioinformaticsmetabologenomicsmicrobial librarybiotech discovery platformsmall molecule discoverycontract researchCROcomputational biologydrug discovery partnerin silico drug discoverybiotech R&DAI-enabled drug discoverydrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MicroMGx Comparables

Compare MicroMGx with similar companies based on industry and business-model similarity.

MicroMGx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adapsyn Bioscience
87%
NAICONS Srl
84%
Clue Genetics Inc.
84%

MicroMGx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 9, 2025
CrowdfundingApr 21, 2023
AcceleratorOct 20, 2022
GrantJan 6, 2017

Key People

Founding team and executive leadership

Jack Kloeber

Chief Executive Officer

Executive Team

MicroMGx Investors

Notable investors and investment history

MicroMGx investors
InvestorRounds
HudsonAlpha Institute for BiotechnologyAccelerator
gener8torAccelerator
NIH RADxGrant
AgLaunch AcceleratorAccelerator
NetcapitalCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors grew 54% MoM, reaching 2.5K.

  • Mar 1, 2026

    Monthly visitors grew 539% MoM, from 252 to 1.6K.

MicroMGx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MicroMGx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MicroMGx's valuation, stock price, and market status.

Firmographic Details

HeadquartersEvanston, Illinois
Employee Range6
Year Founded2015
Last FundingJan 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.